In the five years since Philadelphia’s first hormone-replacement therapy case went to trial, a jury has awarded punitive damages as high as $75 million, more
Pfizer Puts Hormone-Drug Settlement Costs At $772M, May Go Higher
Pfizer Inc. (PFE) expects to pay at least $772 million to resolve all of the product-liability litigation surrounding its hormone-replacement therapy drugs, but the ultimate
Hospitalizations, deaths after needle biopsy tests increasing
Shane Greenstein only vaguely recalls being told that a prostate biopsy he had in June was negative for cancer. That’s because within two days of
